Gurugram-based personal care startup Clarity Labs has raised over Rs. 4 crore in a seed funding round led by Artha Venture Fund II, with participation from angel investors.  The round values the company at approximately Rs. 20 crore pre-money. The capital will be deployed to accelerate product development, expand into new personal care categories, and scale omnichannel distribution — a clear signal that early-stage investors are doubling down on functional, outcome-driven skincare built specifically for Indian consumers.

The Problem Clarity Labs Is Built to Solve

Founded in November 2024 by Karan Dokras, Clarity Labs is built around a straightforward premise: most Indian consumers want better skin but abandon complex routines within weeks. In a market flooded with multi-step regimens and ingredient-overloaded marketing, the brand’s thesis is refreshingly direct — embed effective treatment into the daily habits people already have.

As Dokras put it: “Consumers are increasingly ingredient-literate, but adoption breaks when routines become impractical. We are building products that deliver outcomes in the steps people already repeat every day. So consistency becomes the engine for results, not an additional burden.”

Its flagship line, The BAR, launched in March 2026, targets specific concerns including acne, tan, muscle relief, and sensitive skin — designed around transparent formulations and measurable results. 

Early Traction and What Comes Next

Since launching The BAR, Clarity Labs has expanded its presence across its D2C website, Amazon, and Flipkart. The roadmap includes moving into adjacent wash categories — hair wash, body wash, and face wash — while continuing to build within soaps through new variants and formats. 

The founding team brings meaningful operational depth to this ambition. They have a proven track record of scaling profitable consumer businesses, including building brands to over Rs. 40 crore ARR and scaling monthly revenue from Rs. 10 lakh to Rs. 10 crore within 24 months.

Why Artha Venture Fund Backed Clarity Labs

The investment reflects Artha’s conviction in the founding team’s execution ability as much as the market opportunity. Anirudh A. Damani, Managing Partner at Artha Venture Fund, noted: “What stood out was the clarity of the product thesis and the discipline to build toward repeat-led growth with sensible unit economics across channels; alongside proven depth in procurement, distribution, and compliance.”

Beyond capital, Artha will work closely with Clarity Labs on product and portfolio strategy, brand building, and go-to-market execution across D2C, marketplaces, and quick commerce — and will support the company in expanding offline distribution and pursuing B2B collaborations within the broader AVF ecosystem. This round marks AVF II’s eighth portfolio investment.

What This Means for India’s Functional Skincare Market

Clarity Labs enters a competitive space — alongside brands like DERMATOUCH, Chemist At Play, and Hoop — but with a differentiated angle: affordability, habitual integration, and performance over complexity. The raise comes as India’s functional skincare segment continues to attract early-stage capital, with Artha adding Clarity Labs to a growing portfolio of D2C bets targeting India’s mass-market personal care space.

The broader trend is clear. Indian consumers are increasingly ingredient-aware, but they reward brands that make good skincare effortless rather than aspirational. Clarity Labs is betting that simplicity, done rigorously, is the most defensible position in personal care — and early investor confidence suggests that thesis has legs.